This suppression not only promotes viral replication since inhibition of the IFN signaling using a JAK1/2 inhibitor could restore the replication defect of the Nsp15 mutant (51), but may also contribute to the delayed IFN response observed in COVID-19 patients (52, –, 54). This evidence concerns the gene JAK1 and COVID-19.